These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16188134)
21. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Su XY; Li GD; Liu HB; Jiang LL Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932 [TBL] [Abstract][Full Text] [Related]
22. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody Ber-EP4: its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimens. Maguire B; Whitaker D; Carrello S; Spagnolo D Diagn Cytopathol; 1994; 10(2):130-4. PubMed ID: 8187591 [TBL] [Abstract][Full Text] [Related]
24. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Comin CE; Saieva C; Messerini L Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535 [TBL] [Abstract][Full Text] [Related]
25. Immunofluorescent staining of metastatic carcinoma cells in serious fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA-1 and Ber-EP4. Illingworth AL; Young JA; Johnson GD Cytopathology; 1994 Oct; 5(5):270-81. PubMed ID: 7819512 [TBL] [Abstract][Full Text] [Related]
26. The significance of detecting glucose transporter 1 and calretinin in serous effusions to differentiate between carcinoma cells and reactive mesothelial cells. Lv M; Cha N; Zou YF; Leng JH; Hao YY; Wang S Diagn Cytopathol; 2021 Jul; 49(7):811-816. PubMed ID: 33818924 [TBL] [Abstract][Full Text] [Related]
27. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. Davidson B; Dong HP; Berner A; Christensen J; Nielsen S; Johansen P; Bryne M; Asschenfeldt P; Risberg B Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861 [TBL] [Abstract][Full Text] [Related]
28. [GC12, marker of cells of mesodermal origin. Value and application to cytodiagnosis of serous effusions]. Daste G; Gioanni J; Lauque D; Kremps M; Mazeau C; Paquis P; Schneider M Arch Anat Cytol Pathol; 1997; 45(4):185-91. PubMed ID: 9406475 [TBL] [Abstract][Full Text] [Related]
29. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863 [TBL] [Abstract][Full Text] [Related]
30. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion. Ueda J; Iwata T; Ono M; Takahashi M Diagn Cytopathol; 2006 Jan; 34(1):6-10. PubMed ID: 16355377 [TBL] [Abstract][Full Text] [Related]
31. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep vs cell block. Gong Y; Sun X; Michael CW; Attal S; Williamson BA; Bedrossian CW Diagn Cytopathol; 2003 Jan; 28(1):1-5. PubMed ID: 12508174 [TBL] [Abstract][Full Text] [Related]
32. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis. Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294 [TBL] [Abstract][Full Text] [Related]
33. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies]. Spehn J; Iwanetz S; Schmitz-Huebner U Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771 [TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-EP4. De Angelis M; Buley ID; Heryet A; Gray W Cytopathology; 1992; 3(2):111-7. PubMed ID: 1617160 [TBL] [Abstract][Full Text] [Related]
35. Morphologic and immunocytochemical performances of effusion cell blocks prepared using 3 different methods. Jing X; Li QK; Bedrossian U; Michael CW Am J Clin Pathol; 2013 Feb; 139(2):177-82. PubMed ID: 23355202 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids. Afify A; Zhou H; Howell L; Paulino AF Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901 [TBL] [Abstract][Full Text] [Related]
37. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions. Kundu R; Handa U; Mohan H Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027 [TBL] [Abstract][Full Text] [Related]
38. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Pillai V; Cibas ES; Dorfman DM Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119 [TBL] [Abstract][Full Text] [Related]
39. Ber-EP4 staining in effusion cytology: A potential source of false positives. Díaz Del Arco C; Saiz-Pardo Sanz M; Ortega Medina L; Fernández Aceñero MJ Rev Esp Patol; 2021; 54(2):114-122. PubMed ID: 33726887 [TBL] [Abstract][Full Text] [Related]
40. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]